Pan-Driver-Negatives versus Epidermal Growth Factor Receptor Mutants for C-Stage IA Lung Adenocarcinoma with Ground-Glass Opacity

Purpose: We aimed to verify the prognosis of epidermal growth factor receptor (EGFR) mutation of clinical (c)-stage IA lung adenocarcinoma with the ground-glass opacity (GGO) component. Methods: We evaluated 226 cases of surgically resected c-stage IA lung adenocarcinoma with GGO component. Endpoint...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ming, Xi, Junjie, Zhang, Huan, Jin, Xing, Zhang, Jianrong, Feng, Mingxiang, Zhan, Cheng, Wang, Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585333/
https://www.ncbi.nlm.nih.gov/pubmed/35644565
http://dx.doi.org/10.5761/atcs.oa.22-00058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585333/
https://www.ncbi.nlm.nih.gov/pubmed/35644565
http://dx.doi.org/10.5761/atcs.oa.22-00058

Ejemplares similares